Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00337272 · ClinicalTrials.gov registry record · Phase 4
Treating Chronic Insomnia in Breast Cancer Patients
A Phase 4 study, sponsored by Accelerated Community Oncology Research Network.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00337272 is a Phase 4 study that was terminated before completion, run by Accelerated Community Oncology Research Network. The registered enrollment target is 16 participants.
The verdict
NCT00337272, a Phase 4 study, was terminated before completion, sponsored by Accelerated Community Oncology Research Network.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer.
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00337272
The ClinicalTrials.gov registry entry for NCT00337272 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Accelerated Community Oncology Research Network, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00337272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00337272 about?
NCT00337272 is a clinical study titled "Treating Chronic Insomnia in Breast Cancer Patients". This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer.
What is the current status of trial NCT00337272?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2006-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00337272?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00337272?
This trial is sponsored by Accelerated Community Oncology Research Network, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.